We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 333

PTAB roadshow effort kicks off in Alexandria on 415

  • Oblon Spivak McClelland Maier & Neustadt LLP
  • -
  • USA
  • -
  • April 10 2014

Roughly eighteen months have passed since the USPTO's implementation of the new post grant patent challenges of the America Invents Act (AIA). Since

Senator Leathy announces compromise on Patent Reform Bill

  • Oblon Spivak McClelland Maier & Neustadt LLP
  • -
  • USA
  • -
  • April 9 2014

With many fearing that the Senate Judiciary Committee had lost their way on S.1720 known as The Patent Transparency & Improvement Act, news comes

Senate struggles to recalibrate patent reform bill

  • Oblon Spivak McClelland Maier & Neustadt LLP
  • -
  • USA
  • -
  • April 8 2014

The Senate Judiciary Committee continues to struggle with S.1720 (Patent Transparency & Improvements Act of 2013). Yet again, the Committee has pos

Patent reissue as an alternative to PTAB amendment practice

  • Oblon Spivak McClelland Maier & Neustadt LLP
  • -
  • USA
  • -
  • April 8 2014

As discussed previously, patent owners continue to struggle with the motion-based amendment requirements of the USPTO’s Patent Trial & Appeal Board

Insights from the CLS Bank argument

  • Oblon Spivak McClelland Maier & Neustadt LLP
  • -
  • USA
  • -
  • April 4 2014

The closely watched case of Alice Corp. v. CLS Bank was argued before the Supreme Court of the United States this past Monday. The Court is not

Senate extends Innovation Act mark up a few more days

  • Oblon Spivak McClelland Maier & Neustadt LLP
  • -
  • USA
  • -
  • April 3 2014

Although discussing the Patent Transparency and Improvements Act of 2013 in today’s executive business meeting, the Senate Judiciary Committee

Recalibrated patent reform bill unveiled thursday?

  • Oblon Spivak McClelland Maier & Neustadt LLP
  • -
  • USA
  • -
  • April 2 2014

Last week, the Senate Judiciary Committee generally considered bill S. 1720 entitled Patent Transparency and Improvements Act of 2013 but held over

Is branded biopharma adequately preparing for the PTAB?

  • Oblon Spivak McClelland Maier & Neustadt LLP
  • -
  • USA
  • -
  • March 24 2014

As discussed last week, the USPTO’s Patent Trial & Appeal Board (PTAB) offers significant benefits to generic drug companies seeking to enter the

Generic pharma leverages PTAB

  • Oblon Spivak McClelland Maier & Neustadt LLP
  • -
  • USA
  • -
  • March 20 2014

Since Post Grant Review (PGR) is designed to challenge patents on 112 and 101 grounds not available in Inter Partes Review (IPR), it is often assumed

Medical technology patents at the PTAB

  • Oblon Spivak McClelland Maier & Neustadt LLP
  • -
  • USA
  • -
  • March 18 2014

With Congress on the verge of passing still more legislation directed at alleviating the dreaded “patent troll” problem, perhaps Congress should